Zika virus vaccine (Institut Pasteur of Shanghai/Anhui Zhifei Longcom Biopharmaceutical)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NameZika virus vaccine (Institut Pasteur of Shanghai/Anhui Zhifei Longcom Biopharmaceutical)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Recombinant proteinVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Inactivated vaccine > Subunit vaccine
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsZika Virus Infection
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaPending
Originator CompaniesInstitute of Immunology and Infection, Chinese Academy of Sciences Shanghai
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesInstitute of Immunology and Infection, Chinese Academy of Sciences ShanghaiAnhui Zhifei Longcom Biopharmaceutical Co Ltd
Active IndicationsN/A
Inactive IndicationsZika Virus Infection

Other Information

ATC CodeN/A
Related LinksN/A